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Introduction
The canonical miRNA pathway has an important role in stem 
cell biology, regulating features such as pluripotency and cell 
fate commitment, and its misregulation contributes to human 
diseases. miRNAs are processed from primary transcripts in the 
nucleus by the microprocessor complex, which consists of the 
RNase III enzyme DRO SHA and two DGCR8 double-stranded 
RNA-binding proteins to generate precursor miRNAs (Nguyen 
et al., 2015; Herbert et al., 2016). Precursor miRNAs are then 
exported into the cytoplasm and processed by DIC ER to gen-
erate mature miRNAs. They are then incorporated into the 
RNA-induced silencing complex, leading to the destabiliza-
tion or translational repression of their target transcripts (Am-
bros, 2003; Bartel, 2009).
Several proteins involved in miRNA biogenesis are reg-
ulated by posttranslational modifications (Kim et al., 2009). In 
particular, the ability of DGCR8 to bind RNA is modulated by 
dimerization, in concert with acetylation and phosphorylation 
(Wada et al., 2012; Herbert et al., 2013). The phosphorylation 
of DGCR8 conditions its ability to associate with cofactors. 
Although DGCR8 phosphorylation increased its stability, it 
did not alter its miRNA processing activity, suggesting novel 
functions for this posttranslational modification (Herbert et 
al., 2013). Importantly, noncanonical functions for DGCR8 
have been recently discovered, including the binding to a large 
number of structured RNAs that harbor predicted secondary 
structures resembling that of a primary miRNA, and to cassette 
exons regulating the abundance of alternative spliced isoforms 
(Macias et al., 2012). Finally, recent work revealed an interplay 
between pre-mRNA splicing and the microprocessor within the 
supraspliceosome (Agranat-Tamir et al., 2014).
DGCR8’s function is essential for mouse embryonic de-
velopment, reflected by embryonic lethality postimplantation 
(Wang et al., 2007). Interestingly, Dgcr8 knockout (Dgcr8_
KO) mouse embryonic stem cells (mESCs) present prolifera-
tion and differentiation defects that slightly differ from those 
of Dicer mutant mESCs (Kanellopoulou et al., 2005; Wang 
et al., 2007), suggesting miRNA-independent functions in the 
differentiation process. Several transcription factors are critical 
for the maintenance of the naive pluripotent state of mESCs, 
including OCT4, SOX2, and NAN OG (OSN). Their down-reg-
ulation is essential to exit pluripotency and differentiate in the 
three germ layers (Loh et al., 2015). TCF7L1 (also known as 
TCF3) is an integral component of the core pluripotency net-
work and shares many DNA-binding sites with OSN (Tam et 
al., 2008). Its down-regulation or disruption leads to an en-
hancement of the self-renewal capacity of mESCs and a re-
sistance to differentiation (Yi et al., 2008; Guo et al., 2011). 
Furthermore, Tcf7l1 mRNA is present as two alternatively 
spliced isoforms in mESCs. The Tcf7l1 isoforms have similar 
transcriptional activities in the regulation of mESC renewal 
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and distinct activities in the regulation of their differentiation 
(Salomonis et al., 2010).
Here, we discovered a new role for the DGCR8 protein, 
independent of DRO SHA, regulating the exit from pluripotency 
of mESCs. Moreover, the impaired differentiation of Dgcr8_
KO mESCs is independent of its function in miRNA biogenesis. 
Importantly, proper phosphorylation of the protein is required 
for DGCR8 binding to Tcf7l1 pre-mRNA to facilitate pre-
mRNA splicing to the short isoform and thereby control the exit 
from pluripotency of mESCs. Together, these data reveal a new 
noncanonical function for DGCR8 protein as a key regulator of 
the core pluripotency network in mESCs.
Results and discussion
Dgcr8_KO mESCs do not exit the 
pluripotency state
The fact that Dgcr8 and Dicer mutant mESCs have distinct 
phenotypes indicates that putative noncanonical functions of 
DGCR8 or the role of DIC ER in the siRNA pathway could 
be the underlying cause of these differences (Kanellopoulou 
et al., 2005; Wang et al., 2007). To understand the molecular 
mechanisms causing the differentiation defects in Dgcr8 mutant 
mESCs (Wang et al., 2007), we generated new CRI SPR/Cas9 
mutant cells for the Dgcr8 gene, which mimic the deletion of 
previously described Dgcr8Cre-lox mutant mESCs (Wang et al., 
2007). Two independent genomic deletion events were achieved 
using CRI SPR/Cas9 single guide RNAs (sgRNAs) targeting the 
nuclear localization domain of DGCR8 (Fig. 1 A). Independent 
mESC clones were isolated and the deletion of Dgcr8 confirmed 
at the DNA and protein levels (Fig. S1A and Fig. 1 A), leading 
to a strongly reduced expression of canonical precursor (Fig. S1 
B) and mature miRNAs (Fig. S1, C and D). Conversely, expres-
sion of miR-320 (a microprocessor-independent miRNA) was 
not substantially affected (Fig. S1 C). These mutant cells pro-
liferated at a significantly slower rate than their wild-type (WT) 
counterparts and presented a G1 phase arrest (Fig. S1, E and F).
To assess the differentiation capacity of these mutant 
mESCs, we performed an embryoid body differentiation (EB) 
assay (Fig. 1 B). Molecular analysis revealed that Dgcr8_KO 
mESCs failed to repress the core pluripotency network and 
to induce the expression of differentiation markers from the 
three germ layers (Fig.  1, B and C; and Fig. S1 G). Collec-
tively, newly generated Dgcr8_KO mESCs are impaired in their 
differentiation capacity.
To investigate the commitment to differentiation of our 
knockout mESCs, we performed an exit from pluripotency 
assay (Fig.  1  D; Betschinger et al., 2013). Both Dgcr8_KO 
clones were positive for AP staining and presented stem cell 
morphology, whereas WT mESCs died or were AP negative 
(Fig. 1 D). These results indicate that DGCR8 is essential for the 
exit from pluripotency of mESCs. Furthermore, FACS analysis 
of the coexpression of OCT4/NAN OG and STE LLA/SSEA-1 
pluripotent markers revealed that Dgcr8_KO mESCs cultured 
in serum plus leukemia inhibitor factor (LIF) conditions pre-
sented a reinforced pluripotency network compared with WT 
mESCs (Fig. 1 E and Fig. S1, H and I), similar to cells grown 
in 2i medium (not depicted; Marks et al., 2012). These experi-
ments show that the regulatory circuitry of pluripotent cells can 
be sustained without DGCR8, but it is necessary to exit from the 
self-renewal program and initiate differentiation.
Phosphomutant-complemented Dgcr8_KO 
mESCs rescue miRNA phenotypes but 
cannot exit the pluripotent state
23 phosphorylation sites have been mapped on the DGCR8 pro-
tein (Herbert et al., 2013). Mutation of all of these sites has 
been shown to have no impact on miRNA biogenesis. Never-
theless, their role in noncanonical functions of DGCR8 has 
not been assessed yet. To rescue phenotypes observed in the 
Dgcr8_KO mESCs, we complemented our Dgcr8_KO mESCs 
with WT mouse (mouse), WT human (human), and a phos-
phomutant (mutant) human DGCR8 (described in Herbert et 
al., 2013). DGCR8 protein levels were recovered in all com-
plemented clones (Fig. 2 A), and the presence of the deletion 
in the endogenous Dgcr8 locus was also confirmed (Fig. S2 A). 
It has previously been shown that the absence of miRNA de-
stabilizes Argonaute 2 (AGO2) protein, an important member 
of the RNA-induced silencing complex (Smibert et al., 2013). 
Indeed, miRNAs and AGO2 protein levels were strongly re-
duced in Dgcr8_KO mESCs and restabilized in the comple-
mented clones (Figs. 2 A and S2 B). Moreover, the expression 
of known miRNA target genes was also restored, validating 
the functionality of the miRNAs (Fig.  2  B). Likewise, previ-
ous studies demonstrating the role of miRNAs regulating pro-
liferation and the cell cycle (Cirera-Salinas et al., 2012; Wang 
et al., 2013), distribution profiles, and proliferation rates were 
fully restored in all complemented clones (Fig. S2, C and D). 
Collectively, the complementation of Dgcr8_KO mESCs with 
the different forms of DGCR8 recovered miRNA production, 
the proliferation defect, and cell cycle distribution. Of note, the 
23 phosphorylation sites of DGCR8 protein do not map to the 
DRO SHA-binding site (Herbert et al., 2013). Therefore, it is 
not surprising that the function of DGCR8 in the biogenesis of 
miRNAs is not altered in the complemented mESCs.
Surprisingly, the phosphomutant (Dgcr8mutant) DGCR8- 
complemented mESCs were not able to differentiate, similar to 
Dgcr8_KO mESCs (Fig.  2  C and Fig. S2, E and F). Indeed, 
FACS analysis of the OSN proteins after 10 d of differentiation 
indicated that Dgcr8_KO and Dgcr8mutant mESCs still expressed 
these proteins. In contrast, fewer WT or DGCR8-complemented 
(mouse and human) cells were positive for these factors (Fig. 
S2, E and F). Additionally, Dgcr8_KO and Dgcr8mutant failed to 
differentiate to a directed neuronal precursor cell differentiation 
(unpublished data). These results reveal that correct posttrans-
lational modifications of DGCR8 protein are essential for the 
early differentiation process.
Finally, an exit from pluripotency assay demonstrated that 
similar to Dgcr8_KO, Dgcr8mutant were not capable of exiting 
from the pluripotency state (Fig. 2 D). Collectively, these results 
indicate that Dgcr8mutant mESCs are not able to exit pluripotency, 
despite a restoration of miRNAs expression, cell proliferation, 
and proper cell cycle distribution. Therefore, we hypothesized 
that the exit from pluripotency impairment observed in Dgcr8_
KO mESCs might be independent of the role of DGCR8 in the 
miRNA biogenesis pathway. Furthermore, the phosphorylation 
of DGCR8 could represent another mechanism ensuring tight 
control of the exit from pluripotency in mESCs.
DGCR8 binds Tcf7l1 mRNA, a component 
of the core pluripotency network
To understand the underlying molecular mechanisms respon-
sible for the block of pluripotency exit in Dgcr8_KO mESCs, 
we first assessed the transcriptome of WT and Dgcr8_KO 
DGCr8 is required to exit pluripotency • Cirera-Salinas et al. 357
Figure 1. Differentiation and commitment defects of CRI SPR-Cas9–generated Dgcr8_KO mESCs. (A) Dgcr8 mouse gene CRI SPR-Cas9 schematic design. 
WW corresponds to the Rsp5 domain of the DGCR8 protein, HBD stands for histone binding domain, and DRBD stands for double-stranded RNA binding 
domain. Immunoblot analysis of DGCR8 in WT and Dgcr8_KO mESCs. (B) Illustration of the embryoid body (EB) differentiation assay. Quantitative RT-PCR 
analysis of the differentiation markers (endoderm: Gata6 and Dab2; mesoderm: Brachyury and Fgf8; ectoderm: Nestin and Fgf5) in WT and Dgcr8_KO 
mESCs during EB differentiation. The data are shown as the fold change compared with WT cells at day 0 after normalization to the Rrm2 housekeeping 
gene. Error bars are the mean ± SEM and are representative of three or more experiments. (C) Immunoblot analysis of DGCR8 and the pluripotent marker 
OCT4 after EB differentiation in WT and Dgcr8_KO mESCs. Membranes were stained with Coomassie to ensure equal loading. (D) Schematic representa-
tion of exit from pluripotency assay. Clonal AP staining of cells after exit from pluripotency assay. AP staining was performed in triplicate, and a represen-
tative example is shown. Error bars are the mean ± SEM and are representative of three independent experiments. *, P < 0.05; Student’s t test. (E) Flow 
cytometry analysis of OCT4/NAN OG and STE LLA/SSEA-1 in WT and Dgcr8_KO mESCs. Representative plots of three or more experiments are shown.
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Figure 2. Phosphomutant DGCR8 complementation of Dgcr8_KO mESCs rescues miRNA biogenesis, but not the differentiation or impaired pluripotency 
exit. (A) Immunoblot analysis of DGCR8 and AGO2 proteins in WT, Dgcr8_KO, and complemented Dgcr8_KO mESCs. Expression of α-tubulin was used 
as a loading control. (B) Quantitative RT-PCR analysis of validated miRNA target genes in WT, Dgcr8_KO, Dgcr8mouse, Dgcr8human, and Dgcr8mutant mESCs. 
The data are shown as the fold change compared with WT cells at day 0 after normalization to the Rrm2 housekeeping gene. Error bars are the mean ± 
SEM and are representative of three independent experiments. (C) Quantitative RT-PCR analysis of differentiation markers (endoderm: Gata6 and Dab2; 
mesoderm: Brachyury and Fgf8; ectoderm: Nestin and Fgf5) in WT and Dgcr8_KO and complemented Dgcr8_KO mESCs. The data are shown as the fold 
change compared with WT cells at day 0 after normalization to the Rrm2 housekeeping gene. Error bars are the mean ± SEM and are representative of 
three independent experiments. (D) Clonal AP staining after exit from pluripotency assay in WT, Dgcr8_KO, and complemented Dgcr8_KO mESCs. Error 
bars are the mean ± SEM and are representative of three or more experiments. *, P < 0.05; Student’s t test.
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mESCs by RNA sequencing (RNA-seq). We identified many 
differentially expressed genes implicated in several biological 
pathways (Fig.  3  A, Fig. S3 A, and Table S3). The intersec-
tion of our RNA-seq data with a DGCR8 HITS-CLIP dataset 
(mRNA bound by DGCR8; Macias et al., 2012) and a list of 
candidate genes involved in the exit from pluripotency (Leeb et 
al., 2014) highlighted only four potential candidates that might 
be responsible for the observed phenotype: Ext1, Nav1, Akt3, 
and Tcf7l1 genes (Fig. 3 B).
We decided to confirm the direct binding of DGCR8 to 
the stem-loop structure present in intron four of Tcf7l1 mRNA 
because of its well-established role in the core pluripotency 
Figure 3. DGCR8 directly interacts with Tcf7l1 in a RNA-dependent manner and facilitates its alternative splicing. (A) Volcano plot showing the global 
transcriptional changes in Dgcr8_KO versus WT mESCs. The x axis shows the log fold change, and the y axis shows the −log10 of the p-value. Differen-
tially expressed genes are represented by colored circles and are defined by a fold change greater than two and a false discovery rate <0.1. (B) Venn 
diagram showing the intersection between our RNA-seq, a DGCR8 HITS-CLIP (Macias et al., 2012), and a candidate list of exit from pluripotency genes 
(Leeb et al., 2014). (C) Exon structure graph for Tcf7l1 gene with differences in isoform expression between mESCs and EBs. The detected alternative exon 
is indicated as a black filled box. Dashed line between exons indicates an alternative splicing event. The hairpin structure in intron 4 is depicted as well. 
(D) DGCR8-immunoprecipitated RNA from WT, Dgcr8_KO, Drosha_KO, and complemented Dgcr8_KO mESCs. RIP was performed in triplicate, and a 
representative example is shown. INP UT, RNA isolated from input samples; RIP, RNA isolated from the immunoprecipitated DGCR8; IgG, RNA isolated 
from the immunoprecipitated IgG control. (E) Quantitative RT-PCR of long and short Tcf7l1 mRNA in WT, Dgcr8_KO, complemented Dgcr8_KO, and Dro-
sha_KO mESCs. The data are shown as relative expression after normalization to the Rrm2 housekeeping gene. Error bars are the mean ± SEM and are 
representative of three or more experiments. (F) RT-PCR of alternative splicing events in Tcf7l1 before (day 0) and after 10 d of differentiation (day 10). 
PCR amplicons from exons 3–4, exons 5–6, and Rrm2 were used as a control. Ratio: long Tcf7l1/short Tcf7l1. (G) Minigene splicing reporter analysis. 
Alternative splicing events in 1% agarose gel from independent single clones in WT and Dgcr8_KO mESCs. A mixed population of WT cells was used as 
a control. Representative gels of three or more experiments are shown. *, P < 0.05; Student’s t test.
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network (Pereira et al., 2006; Cole et al., 2008; Marson et al., 
2008; Tam et al., 2008; Salomonis et al., 2010; Leeb et al., 
2014; Fig. 3 C). RNA immunoprecipitation (RIP) experiments 
demonstrated that DGCR8mutant protein was not able to bind 
Tcf7l1 mRNA, contrary to WT, DGCR8mouse, and DGCR8human 
(Fig. 3, C and D; and Fig. S3, B and C). The phosphosite mu-
tations might affect the charge of the protein and therefore 
change its affinity to Tcf7l1 mRNA. Furthermore, we generated 
Drosha_KO mESCs (Fig. S3 D) and assessed the binding of 
DGCR8 to Tcf7l1 mRNA. RIP of Tcf7l1 mRNA with DGCR8 
protein in Drosha_KO mESCs demonstrated that DGCR8 binds 
Tcf7l1 mRNA independently of the microprocessor complex. 
These experiments confirm previous studies of interactions be-
tween DGCR8 protein and Tcf7l1 mRNA (Macias et al., 2012) 
and reveal that this interaction is dependent on correct post-
translational modifications of DGCR8 protein.
Moreover, we monitored the expression of the four can-
didates in all mESC clones (Figs. 3 E and S3 E). Only the 
expression of the long Tcf7l1 isoform was up-regulated in 
Dgcr8_KO and Dgcr8mutant clones compared with the other 
mESCs (Fig. 3 E). Interestingly, the short Tcf7l1 isoform was 
expressed at comparable low levels among all clones, as ex-
pected in undifferentiated stem cells (Salomonis et al., 2010). In 
conclusion, the ratio between the long and short Tcf7l1 mRNAs 
was higher in Dgcr8_KO and Dgcr8mutant clones. Therefore, we 
hypothesized that the differential expression of the long Tcf7l1 
isoform expression could explain the impaired pluripotency exit 
phenotype observed. Of note, Tcf7l1 was also present in our list 
of differentially spliced genes in Dgcr8_KO mESCs (Table S4).
Subsequently, we demonstrated that after 10 d of differen-
tiation, the two Tcf7l1 isoforms were still detected in Dgcr8_KO 
and Dgcr8mutant clones as in undifferentiated mESCs (Fig. 3 F). 
Furthermore, to assess the role of DGCR8 in the splicing of 
Tcf7l1 mRNA, we designed a minigene vector harboring, from 
the Tcf7l1 gene, exon 4, the part of the intronic region contain-
ing the DGCR8 interacting loop, and exon 5 (Fig. 3 G). After 
transient transfection in WT cells (mixed population), spliced 
and unspliced isoforms could be detected. Nevertheless, inde-
pendent stable Dgcr8_KO clones were unable to splice the min-
igene construct, whereas independent stable WT mESCs spliced 
it correctly (Fig. 3 G). Collectively, these data demonstrate that 
DGCR8 is essential for the correct splicing of Tcf7l1 mRNA.
DGCR8 controls cell pluripotency and 
differentiation through the alternative 
splicing of Tcf7l1 mRNA
Next, we investigated the role of the long Tcf7l1 isoform in the 
impaired exit from pluripotency phenotype. Down-regulation 
of the long Tcf7l1 mRNA by siRNA during the exit from plu-
ripotency assay allowed significantly more Dgcr8_KO and 
Dgcr8mutant mESCs to commit to differentiation (Fig. 4 A and 
Fig. S3, F and G). These results suggest a role for the long Tcf7l1 
isoform or for an appropriate ratio between the two isoforms in 
the reinforcement of the pluripotency state in Dgcr8_KO and 
Dgcr8mutant mESCs. We detected homogenous coexpression of 
OCT4/NAN OG and STE LLA/SSEA-1 pluripotency factors 
in Dgcr8mutant mESCs, similar to Dgcr8_KO, contrary to the 
intermediate heterogeneity observed in WT, Dgcr8mouse, and 
Dgcr8human mESCs (Fig. 4 B).
siRNA against the long or short Tcf7l1 isoforms had the 
most profound overall effect when transfected during differenti-
ation of the cells. Dgcr8_KO and Dgcr8mutant cell differentiation 
was partially restored when the long Tcf7l1 was suppressed 
as shown by the down-regulation of pluripotent markers and 
the up-regulation of several differentiation makers (Fig. 4 C). 
Conversely, down-regulation of the short Tcf7l1 isoform in-
hibited the differentiation of WT mESCs (Fig. 4 C). Moreover, 
down-regulation of long or short Tcf7l1 isoforms in mESCs had 
different transcriptomic consequences on known targets (Salo-
monis et al., 2010), demonstrating the different transcriptional 
effects of the two isoforms (Fig. S3 H).
To finally demonstrate the importance of the short Tcf7l1 
isoform in mESC differentiation, we stably expressed it, in an 
inducible manner, in WT and Dgcr8_KO mESCs. The forced 
expression of the short Tcf7l1 (Fig. S3 I) caused a dramatic 
down-regulation of pluripotency (OCT4/NAN OG and Rex1) 
and up-regulation of differentiation (Dnmt3b) markers in WT 
and Dgcr8_KO mESCs (Fig. 5, A and B). Collectively, these 
data demonstrate that the down-regulation of the long Tcf7l1 
isoform and the up-regulation of the short Tcf7l1 isoform pro-
mote the exit from pluripotency and differentiation of mESCs.
In conclusion, DGCR8 is required for the splicing of the 
long Tcf7l1 isoform and a correct balance between the two iso-
forms, facilitating the activation of cell lineage–specific pro-
grams. We propose a working model recapitulating our findings 
(Fig. 5 C). Finally, our results explain the previously observed 
impaired differentiation process of Dgcr8_KO mESCs and re-
veal a new noncanonical function of DGCR8 essential for the 
exit from pluripotency of mESCs.
Materials and methods
Materials
Chemicals were obtained from Sigma-Aldrich unless otherwise noted.
Cell culture
The E14TG2a mESC (CRL-1821; ATCC) line was used for WT 
mESCs. Cells were cultured into DMEM (Invitrogen) supplemented 
with 15% of a selected batch of FBS (Gibco) tested for optimal mESC 
growth, 1,000 U/ml LIF (EMD Millipore), 0.1 mM 2-β-mercaptoetha-
nol (Thermo Fisher Scientific), 0.05 mg/ml streptomycin, and 50 U/ml 
penicillin (Sigma-Aldrich). Cells were grown on 0.2% gelatin-coated 
cell culture–grade plastic vessels in the absence of feeder cells. For 
the differentiation assays, cells were cultured in differentiation me-
dium composed of DMEM supplemented with 10% FBS, 0.1  mM 
β-mercapto-ethanol (Thermo Fisher Scientific), 0.05 mg/ml streptomy-
cin, and 50 U/ml penicillin (Sigma-Aldrich). Cells were cultured in 
suspension in low-adherent tissue culture dishes from day 1 to day 6 
and then reattached on adherent 0.2% gelatin-coated flask and collected 
at day 10. All cells were grown at 37°C in 8% CO2, and the culture 
medium was changed daily.
Generation of Dgcr8_KO and Drosha_KO mESCs using CRI SPR/Cas9
Dgcr8_KO and Drosha_KO mESCs were generated from E14TG2a 
mESCs using a paired CRI SPR/Cas9 strategy (Wettstein et al., 2016). 
The plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9 (plasmid 42230; 
Addgene) was used. Cells were single-cell sorted 48 h after transfection 
using a flow cytometry cell sorter (MoFlo; BD) into 96-well plates (one 
single cell per well). The first screening for selection of candidates 
was performed at the genomic level by PCR. All of the primers used 
for CRI SPR/Cas9 constructions and PCR screening are described 
in Table S1. Specific CRI SPR/Cas9 sgRNAs were generated using 
E-CRI SPR software (Heigwer et al., 2014) or alternatively chosen 
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Figure 4. Down-regulation of long Tcf7l1 promotes exit from pluripotency and differentiation of mESCs. (A) Exit from pluripotency assay after knockdown 
of the long Tcf7l1 isoform in WT, Dgcr8_KO, and complemented Dgcr8_KO mESCs. (B) Flow cytometry analysis of OCT4/NAN OG and STE LLA/SSEA-1 
in WT, Dgcr8_KO, and complemented mESCs. Representative plots of three independent experiments are shown. Error bars are the mean ± SEM and are 
representative of three independent experiments. (C) Quantitative RT-PCR analysis of pluripotency (OSN, top) and differentiation (bottom) markers in WT, 
Dgcr8_KO, and complemented Dgcr8_KO mESCs upon knockdown of long or short Tcf7l1 isoforms with siRNA every 48 h. Rrm2 housekeeping gene was 
used as reference. For each gene, data were normalized to the mRNA at day 0. Error bars are the mean ± SEM and are representative of three or more 
experiments. *, P < 0.05; Student’s t test.
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Figure 5. Up-regulation of short Tcf7l1 promotes exit from pluripotency and differentiation of mESCs. Flow cytometry analysis of OCT4/ NAN OG (A) and 
quantitative RT-PCR analysis of pluripotent (Rex1) or early differentiation (Dnmt3b) markers in WT and Dgcr8_KO mESCs upon induction of the short Tcf7l1 
(+dox) for 3 d in serum plus LIF (top) or differentiation (bottom) media (B). Representative plots of three or more experiments are shown. Quantification is 
shown on the right. *, P < 0.05; Student’s t test. The data are shown as the fold-change compared with WT cells at day 0 after normalization to the Rrm2 
housekeeping gene. Error bars are the mean ± SEM and are representative of three independent experiments. (C) Putative model of action: DGCR8, under 
normal post-translational modifications, is able to directly interact with the intronic hairpin of the Tcf7l1 mRNA facilitating the recruitment of the spliceosome. 
The short Tcf7l1 isoform will allow the differentiation of mESCs (Cavallo et al., 1998; Pereira et al., 2006). When DGCR8 is not present (Dgcr8_KO) or 
hypophosphorylated (Dgcr8mutant), it cannot bind to the stem loop structure present in Tcf7l1 mRNA, leading to an inefficient splicing of Tcf7l1. This long 
Tcf7l1 isoform, enriched in stem cells and down-regulated during differentiation, has been shown to repress lineage specification genes (Wray et al., 2011; 
Yi et al., 2011). In conclusion, the ratio between the two Tcf7l1 isoforms controls mESCs pluripotency and differentiation.
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from an established library (Koike-Yusa et al., 2014). All designs 
are based on the latest mouse genome assembly (GRCm38/mm10) 
provided by the University of California, San Cruz, Genome browser 
(http ://genome .ucsc .edu /).
Complementation of mESCs
WT or Dgcr8_KO mESCs cells were transfected into six-well plates 
using Lipofectamine 2000 (Thermo Fisher Scientific) with 2 µg plasmid 
per well. Cells were plated 24 h before transfection at 200,000 cells per 
well and cultured in culture medium without streptomycin and penicil-
lin. The medium was changed to normal culture medium 8 h after trans-
fection. After 3 d in the selection media, cells were single sorted into 
96-well plates to achieve single-cell colonies. Cells were always cul-
tured in selection media, and positive clones were screened at the DNA, 
mRNA, or protein level. For DGCR8 complementation, Dgcr8_KO–
complemented mESCs were achieved by stable transfection of mouse, 
human, and phosphomutant DGCR8 plasmids (Herbert et al., 2013). 
Stable independent mESC clones were selected in 250 µg/µl G418- 
containing medium. For the minigene and short inducible TCF7L1, 
stable clones were selected in 1 µg/µl puromycin–containing medium.
Plasmids
sgRNAs were individually cloned into the plasmid pX330-U6-Chi-
meric_BB-CBh-hSpCas9 using the BbsI restriction site as previously 
described (Cong et al., 2013). The plasmid pX330-U6-Chimeric_BB-
CBh-hSpCas9 was a gift from F.  Zhang (Massachusetts Institute of 
Technology, Cambridge, MA; plasmid 42230; Addgene). All of the 
primers used for the generation of new plasmids are described in Table 
S2. The human DGCR8 plasmids were a gift from J. Steitz (Yale School 
of Medicine, New Haven, CT). To generate WT human and phos-
phomutant DGCR8 constructs under a suitable promoter for stem cell 
expression, we subcloned the sequence from the original vectors (Her-
bert et al., 2013) with EcoRI and BglII restriction sites into a pMSCV- 
neomycin (Takara Bio Inc.). The WT mouse DGCR8 form was am-
plified by RT-PCR with primers containing the EcoRI and BglII re-
striction sites. The minigene plasmid was designed with the HiFi DNA 
Assembly Tool from the New England Biolabs, Inc. website. The exon 
4, intronic loop and exon 5 of Tcf7l1 were cloned into the pMSCV-puro 
vector backbone after digestion with XhoI restriction enzyme. For 
the easy identification of alternative spliced and WT isoforms, GFP 
gene-specific primers were added to the external primers (Table S1). 
For the inducible overexpression of the short Tcf7l1 isoform, the cDNA 
corresponding to the short Tcf7l1 isoform was cloned from WT mouse 
differentiated cells into the inducible vector pCW57.1 (plasmid 41393; 
Addgene) with an infusion cloning kit (Takara Bio Inc.). The expression 
of the transgene was induced by the addition of 1 µg/ml doxycycline.
Minigene
This construct carries the stem loop present in intron 4 of the Tcf7l1 
gene (840 bp) bound by DGCR8 plus exons 4 and 5 (83 and 133 bp, 
respectively) cloned into the pMSCV-puro vector backbone. In addi-
tion, we added GFP sequences to the 5′ and 3′ ends of the amplified se-
quence for easy identification. We transiently transfected our Minigene 
construct in WT mESCs and performed RT-PCR 48 h later with GFP 
primers (mixed population). Two bands corresponding to the spliced 
and unspliced isoforms were detected (217 and 1,057 bp, respectively). 
Next, we transfected our minigene construct and single cloned selected 
WT and Dgcr8_KO mESCs with stable expression under puromycin 
selection. RT-PCR amplification in WT clones led to a unique band 
corresponding to the exon 4 and exon 5 spliced form (217 bp). Contrary 
to this finding, single Dgcr8_KO mESCs presented a unique band of 
1,057 bp corresponding to the unspliced form.
Genomic DNA extraction and PCR
mESCs were lysed (Tris-HCl 1M, EDTA 0.5M, SDS 20%, NaCl 
5M, and ddH2O) for 4  h at 60°C using proteinase K at 1 mg/ml 
(Sigma-Aldrich). Genomic DNA was extracted from 1 × 106 mESC 
pellets using Roti phenol/chloroform/isoamyl alcohol (Roth). Each 
PCR reaction was performed using 50 ng genomic DNA, and the PCR 
products were separated on a 1% agarose gel containing ethidium bro-
mide. Genotyping PCR primer sequences are described in Table S1.
Quantitative RT-PCR analysis
Total cellular RNA was extracted from 1 × 106 mESC pellets using 
TriZOL Reagent (Thermo Fisher Scientific). Extracts quality was ver-
ified by loading 1 µg total RNA on a 1% agarose gel. A total of 2 µg 
cellular RNA was treated with DNase (RQ1 Rnase-Free DNase kit; 
Promega) and then reverse transcribed according to the manufactur-
er’s protocol using a GoScript Reverse transcription kit (Promega). For 
each extract, PCR on the Rrm2 gene was performed, before and after 
reverse transcription treatment, to ensure the absence of genomic DNA 
contamination. Quantification of expression levels was performed on a 
Light Cycler 480 (Roche) using 2 µl of the diluted cDNAs (1:5) and the 
KAPA SYBR FAST qPCR kit Optimized for Light Cycler 480 (KAPA 
Biosystems). Differences between samples and controls were calcu-
lated based on the 2−ΔCT method. Quantitative RT-PCR assays were 
performed in triplicate. All the primers needed for the quantitative RT-
PCR assays are described in Table S1. For miRNA quantification, 1 µg 
total RNA was reverse transcribed using the miScript II Reverse Tran-
scription kit (QIA GEN) according to the manufacturer’s instructions. 
After the reverse transcription reactions, cDNA products were diluted 
five times in distilled water, and 2 µl of the diluted cDNAs was used for 
PCR using a KAPA SYBR FAST qPCR kit Optimized for Light Cycler 
480 (KAPA Biosystems) and miScript Universal Primer (QIA GEN; 
Table S1). PCR reactions were conducted at 95°C for 10 min, followed 
by 40 cycles at 95°C for 15 s and 60°C for 30 s on a LightCycler 480 
real-time PCR machine (Roche).
Immunoblotting analysis and antibodies
Total cellular protein was extracted from 1 × 106 mESC pellets using a 
NP-40–based lysis buffer (1% NP-40, 137 mM NaCl, 20 mM Tris-HCl, 
and 1 mM EDTA) complemented with EDTA-free protease inhibitor 
cocktail (Roche). Protein concentrations were determined by Bradford 
Assay (Bio-Rad Laboratories). For each sample, 20 µg total cellular 
protein was separated in 8% to 10% SDS-PAGE gels and transferred 
on polyvinylidene fluoride membranes. The following antibodies were 
used: DGCR8 C-terminal antibody 1:2,000 diluted (10996–1-AP; 
Proteintech), anti-Oct-3/4 antibody 1:5,000 diluted (611202; BD), 
Nanog-XP antibody 1:5,000 diluted (D2A3; Cell Signaling Tech-
nology), anti-SOX2 antibody 1:10,000 diluted (ab97959; Abcam), 
anti-DRO SHA (D28B1) rabbit mAb (3364; Cell Signaling Technol-
ogy), TCF-3 antibody 1:1,000 diluted (8635; Santa Cruz Biotechnol-
ogy, Inc.) was a gift from A. Wutz (ETH Zurich, Zurich, Switzerland), 
α-tubulin antibody 1:10,000 diluted (A01410; GenScript), rabbit 
IgG HRP-linked antibody 1:20,000 diluted (08/2012; Cell Signaling 
Technology), and mouse IgG HRP-linked antibody 1:5,000 diluted 
(09/2012; Cell Signaling Technology). Immunoblots were developed 
using the Clarify Western ECL substrate (Bio-Rad Laboratories) kit 
and detected using an imaging system (ChemiDoc MP; Bio-Rad Labo-
ratories). All membranes were probed with an anti–α-tubulin antibody 
or Coomassie blue staining to ensure equal loading.
Low-molecular-weight Northern analysis
Total cellular RNA was extracted from 1 × 106 mESC pellets using 
TriZOL Reagent (Thermo Fisher Scientific). A total of 10 µg total RNA 
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was resuspended in 30 µl final of 50% deionized formamide, loaded 
on a 17.5% acrylamide gel (30% acrylamide/bis solution 19:1; Bio-
Rad Laboratories), blotted for 1 h on a nylon membrane (Amersham 
Hybond-NX; GE Healthcare) in 0.5× TBE (Tris/borate/EDTA) buffer 
at 25 V and 1.5 mA per square centimeter of membrane in a semidry 
system. Membranes were then ethyl-dimethyl-aminopropylcarbodiim-
ide cross-linked. Prehybridizations and hybridizations were both per-
formed in PerfectHyb Plus Hybridization Buffer (Sigma-Aldrich) at 
42°C. All washes were performed in SSC 2×, SDS 0.1%. Radioactive 
signals were detected with an FLA-7000 device (Fujifilm). For sub-
sequent reprobing, membranes were stripped with boiling 0.1% SDS. 
miRNA and U6 probes were generated by labeling specific oligonu-
cleotides at the 5′ end using T4 polynucleotide kinase (New England 
Biolabs, Inc.) and 25 µCi γ[32P]-ATP (3,000 Ci/mmol) and following 
the manufacturer’s instructions. Probes were then purified on Illustra 
MicroSpin G-25 Columns (GE Healthcare). All of the probes used for 
miRNA Northern blots are described in Table S1.
DCGR8 RIP
1 × 107 mESCs were washed in 1× cold PBS, scraped, and then lysed 
with a buffer containing 0.5% Nonidet, 0.5 mM DTT, 20 mM Tris-HCL, 
pH 7.5, 150 mM KCl, 2 mM EDTA, and inhibitors of RNases, prote-
ases, and phosphatases (Thermo Fisher Scientific). 10% of total lysate 
was removed and kept as the input samples and the remainder used 
for immunoprecipitation. 10 µg anti-DGCR8 (Proteintech) or anti-IgG 
(Sigma-Aldrich) antibody was bound to Sepharose beads (Protein A; 
Invitrogen) in the presence of heparin. Precleared lysates were then 
incubated with the appropriate antibody-bound beads, and the immu-
noprecipitated proteins were then washed (150 mM KCl, 25 mM Tris, 
pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% NP-40, and RNase, protease, 
and phosphatase inhibitors) and incubated with DNase I in the presence 
of DNase buffer (Promega) followed by protease K (New England Bio-
labs, Inc.) in the presence of 2× protease buffer (New England Biolabs, 
Inc.). RNA extraction was then performed using phenol-chloroform 
extraction and ethanol/sodium acetate precipitation. RNA pellets were 
washed in ethanol, resuspended in 100 µl water, and quantified using a 
BioPhotometer (Eppendorf).
Exit from pluripotency assay
For the exit from pluripotency assay, 2,000 mESCs were plated in six-
well plate at a density of 4,500 cells/cm2 and then cultured for 3 d 
in 2i medium (N2B27 +2i +LIF) to adapt the cells to the pluripotent 
conditions, followed by 4 d of culture in one of two alternative per-
missive medias (N2B27 without inhibitors or LIF; Figs. 1 D and 2 
D; or DMEM + 10% serum; Fig. 4 A) and subsequently for 3 d in 2i 
medium. The 2i medium was composed of N2B27 (Y40002; Cellartis) 
complemented with PD032591 at 1  µM final concentration (72184; 
STE MCE LL Technologies), CHIR99021 at 3  µM final concentra-
tion (72054; STE MCE LL Technologies), 1,000 U/ml of LIF (EMD 
Millipore), 0.05 mg/ml streptomycin, and 50 U/ml penicillin (Sigma- 
Aldrich). AP staining was performed using the Alkaline Phosphatase 
kit (86R-1KT; Sigma-Aldrich) following the manufacturer’s instruc-
tions. For the quantification of AP positive colonies number, entire six-
well plates used for AP staining assays were first scanned to capture 
the total plate area in a single image. Then, images were processed 
using the ImageJ software (Nanes, 2015). The number of AP-positive 
colonies was calculated on threshold intensity (default parameters) of 
inverted regions that were user-selected (full well or identical areas 
between conditions) using the Analyze Particles tool (default param-
eters). The total number of AP-positive colonies is depicted in the 
graph as a clonal assay.
Proliferation assay
Cells were plated in six-well plates at 75,000 cells per well, and prolifera-
tion was assessed every day for 3 d using the CellTiter-Glo Luminescent 
Cell Viability Assay (G7571; Promega) following the manufacturer’s 
instructions. Proliferation assays were performed in triplicate.
Cell cycle analysis
Asynchronous cells were harvested, washed twice with ice-cold PBS, 
and fixed in 70% ethanol (a minimum of 24-h incubation at −20°C). 
Cells were treated with ribonuclease A at 100 µg/ml (R6148; QIA GEN) 
and incubated in 50 µg/ml propidium iodide for 1 h at 37°C, protected 
from light. Cells were analyzed by flow cytometry (LSRFortessa; BD) 
using selective gating to exclude the doublets of cells and subjected to 
MOD FIT analysis (Verity Software House, Inc.). Percentages of cells 
in G1, S, and G2/M phase were calculated using FLO WJO 7.6.1 soft-
ware. Cell cycle assays were performed in triplicate.
Flow cytometry analyses
Immunostaining and flow cytometry analyses were performed accord-
ing to standard procedures. Cells were harvested, washed with PBS, and 
fixed with 4% paraformaldehyde for 15 min at 37°C. Next, cells were 
permeabilized for 10 min in 90% methanol on ice. After 1 h at room 
temperature with the first antibody, secondary antibody was used for 30 
min at room temperature. The OCT-4 and NAN OG antibodies used are 
previously listed (immunoblot staining). STE LLA antibody (M-150) 
was purchased from Santa Cruz Biotechnology, Inc. (sc-67249), and 
anti–human/mouse SSEA-1 eFluor660 antibody was purchased from 
eBioscience (50-8813-42). Secondary antibodies were purchased from 
Invitrogen (goat anti–mouse IgG–Alexa Fluor 488 or goat anti–rabbit 
IgG–Alexa Fluor 546). All antibodies for FACS experiments were 
used at 1:100 dilutions. Cells were analyzed by flow cytometry (LSR-
Fortessa; BD) using selective gating to exclude the doublets of cells 
(see legends to Fig. S1, H and I; and Fig. S2 E) and FLO WJO 7.6.1 
software. FACS experiments were performed at least three times.
siRNA transfection
mESCs were transfected every 48 h with 60 nM siRNA against long 
or short Tcf7l1 isoforms (Salomonis et al., 2010) or scrambled control 
(Mycrosynth) with RNAimax (Invitrogen) following the manufactur-
er’s instructions during the exit of pluripotency and EB differentiation 
assays (Fig. 4). Verification of Tcf7l1 knockdown was determined by 
quantitative RT-PCR and immunoblot analysis, as described before.
Statistics
All data are expressed as ±SEM. Statistical differences were mea-
sured by Student’s t test. A value of P < 0.05 was considered sig-
nificant. Data analysis was performed using GraphPad Prism 
5.0a software (GraphPad).
RNA-seq
Total cellular RNA was extracted from 1 × 106 mESC pellets using 
TriZOL Reagent (Thermo Fisher Scientific). The quality of isolated 
RNA was determined with a Bioanalyzer 2100 (Agilent Technologies) 
and up to 2 µg poly(A)-purified RNA was used for the library preparation 
TruSeq Paired-end stranded RNA Preparation kit (Illumina) according 
to the manufacturer’s instructions. Library preparation and sequencing 
(Illumina HiSeq 2000) were performed at the Functional Genomics Cen-
ter Zurich. Paired-end sequencing generated ∼2 × 60 million reads per 
library. Reads from RNA-seq were first preprocessed by trimmomatic 
(v0.32; Bolger et al., 2014) to remove low-quality ends and adapters. 
Then, reads were aligned to mouse genome mm10 by STAR (v2.4.2a; 
Dobin et al., 2013) allowing for at most two mismatches. FeatureCount 
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(v1.4.5-p1; Liao et al., 2014) was used to count reads for each gene (En-
sembl GRCm38.78), ignoring reads on overlapped regions and multi-
ple-hit reads. Differentially expressed genes were defined by both edgeR 
(v3.12.0; Robinson et al., 2010) and DESeq2 (v1.10.0; Love et al., 2014), 
with fold change greater than two and false discovery rate <0.1. Differen-
tially spliced events were identified using DEXSeq (v1.16.7) with false 
discovery rate <0.01 (Anders et al., 2012). A volcano plot was generated 
using ggplot2 (1.0.1; Ginestet, 2011). Pathway analysis was performed 
using the Consensus PathDB-mouse database (Kamburov et al., 2013).
Data access
Complete RNA-seq data of WT and Dgcr8_KO mESCs are available 
on the NCBI Gene Expression Omnibus database (GSE78971 for WT 
mESCs and GSE78974 for Dgcr8_KO mESCs).
Online supplemental material
Fig. S1 is a characterization of new CRI SPR/Cas9 Dgcr8_KO mESCs. 
Fig. S2 shows that complemented Dgcr8mutant mESCs restored prolif-
eration and cell cycle defects but cannot differentiate. Fig. S3 shows 
differentially expressed gene pathway analysis, characterization of new 
CRI SPR/Cas9 Drosha_KO mESCs, RIP control experiments, and long 
and short Tcf7l1 differential transcriptional activity experiments and 
control experiments. Table S1 lists primers. Table S2 lists newly gener-
ated plasmids. Table S3 lists differentially expressed genes in Dgcr8_
KO compared with WT mESCs. Table S4 lists differentially spliced 
genes in Dgcr8_KO compared with WT mESCs.
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